Chinese medicine shows global charm, emerging market exports rise

According to the information from the 115th Canton Fair, at a time when the global recovery is still slow, China's pharmaceutical industry still maintains a positive momentum of development, and China is gradually moving from a pharmaceutical power to a pharmaceutical power Meng Dongping, vice president of China Chamber of Commerce for the import and export of healthcare products, said in an interview Wednesday that China has become one of the pharmaceutical markets with potential and investment value for Zui in the world At the same time, China's pharmaceutical industry has also been transformed and upgraded under the driving force of innovation, gradually showing the strength and charm of China's foreign trade medicine to the world Compared with other traditional industries, such as mechanical and electrical industry and clothing industry, the pharmaceutical industry in China is still a new industry with strong vitality and bright prospects Meng Dongping said According to reports, China's pharmaceutical industry has maintained a growth rate of more than twice the national GDP for quite a long time According to the data provided by China Medical Insurance chamber of Commerce, in the first quarter of this year, the overall foreign trade of Chinese medicine was relatively stable, with a year-on-year growth of 8.4%, of which the growth rate of traditional Chinese medicine products was nearly 15%; the growth rate of Western medicine import and export was 9.4% year-on-year; at the same time, the growth rate of pharmaceutical products import was 15% The synchronous growth of import and export shows that China's pharmaceutical industry is now realizing the unified allocation of global pharmaceutical resources, which is a rare industrial phenomenon in the past In Meng Dongping's view, it is through transformation and upgrading that China's pharmaceutical industry can break through the restrictions of economic cold current and trade threshold, and achieve adverse growth According to reports, countries have strict standards for access to medical and health products These high thresholds once became the obstacles for Chinese medicine to go out and participate in international competition Many Chinese pharmaceutical enterprises have made continuous efforts to improve standardized management level from product research and development, production, inspection to logistics through high-tech means In 2013, the number of Chinese pharmaceutical enterprises passing the EU CEP certification increased by 56%, and the total number of valid certificates reached 428 At the same time, the number of enterprises obtaining the US approved DMP documents also increased, and the total number of approved DMP documents reached 1116 Meng Dongping told reporters that more and more Chinese enterprises are applying for or passing quality standard certification in Europe, America and Australia At the 115th Canton Fair, traditional Chinese medicine is being recognized and accepted by more foreign businessmen Li Xiaoyu, vice president of Fujian xianzhilou Pharmaceutical Technology Co., Ltd., told reporters that a few years ago, the Ganoderma lucidum placed on the exhibition stand of Guangzhou Fair was mistaken as mushroom by overseas purchasers Now, many purchasers have rich experience and cognition of Chinese Xiancao We have obtained safety certificates of more than ten quality certification systems in the world, which is the technical basis for us to win market recognition It also shows that traditional Chinese medicine products are completely possible to connect and interact with modern market system and medical and health product certification She said Meng Dongping said that in terms of export market layout, Chinese pharmaceutical enterprises are adjusting The export of Chinese pharmaceutical enterprises in Oceania, ASEAN, Russia and other emerging markets has increased steadily, with the export growth of 20% last year alone At present, the Chinese government is increasing the impetus for these pharmaceutical enterprises from big to strong The government has issued a series of policies and measures to help brand enterprises with cluster advantages and strength to achieve international development The Ministry of Commerce has established more than ten pharmaceutical enterprise transformation and upgrading bases Up to now, China has established intergovernmental agreements with dozens of countries on the content of TCM exchange and cooperation Meng Dongping believes that China is on its way from a pharmaceutical power to a powerful one With the joint efforts of the government, industry and enterprises, the future of China's pharmaceutical industry to show its strength and charm to the global market can be expected.